Edition:
United States

MDxHealth SA (MDXH.BR)

MDXH.BR on Brussels Stock Exchange

4.12EUR
7:54am EDT
Change (% chg)

€0.04 (+0.98%)
Prev Close
€4.08
Open
€4.08
Day's High
€4.15
Day's Low
€4.00
Volume
83,907
Avg. Vol
83,985
52-wk High
€4.24
52-wk Low
€2.80

MDXH.BR

Chart for MDXH.BR

About

MDxHealth SA is a Belgium-based company that develops and commercializes epigenetic assays and service testing for cancer assessment and the personalized treatment of patients. The Company’s offerings are structured into two divisions: Clinical Molecular Diagnostics (ClinicalMDx) solutions, providing physicians with tests which... (more)

Overall

Beta: 0.98
Market Cap(Mil.): €184.59
Shares Outstanding(Mil.): 45.27
Dividend: --
Yield (%): --

Financials

  MDXH.BR Industry Sector
P/E (TTM): -- 44.84 37.54
EPS (TTM): -0.36 -- --
ROI: -37.71 -0.27 13.98
ROE: -38.80 -2.93 14.88

BRIEF-MDxHealth signs distribution agreement in Poland

* MDxHealth and the European Health Centre Innovation sign distribution agreement for SelectMDx and ConfirmMDx in Poland Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

Sep 28 2016

BRIEF-MDxHealth announces positive medical coverage policy for ConfirmMDx

* MDxHealth announces Independence Blue Cross rendered positive medical coverage policy for ConfirmMDx Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

Sep 27 2016

BRIEF-MDxHealth gets Medi-Cal Approval for ConfirmMDx

* Announced that ConfirmMDx for prostate cancer test is now available as an in-network benefit under California Medical Assistance Program (Medi-Cal) Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

Sep 06 2016

BRIEF-Mdxhealth and Teva sign distribution agreement for selectMDX in Israel

* Mdxhealth and Teva pharmaceuticals sign distribution agreement for selectMDX in Israel Source text for Eikon: Further company coverage:

Aug 31 2016

BRIEF-MDxHealth and Teva Pharmaceuticals sign distribution deal

* MDxHealth and Teva Pharmaceuticals sign distribution agreement for SelectMDx in Israel

Aug 31 2016

BRIEF-Mdxhealth H1 net loss widens to 7.6 million US dollars

* H1 EBITDA loss of USD 6.7 million versus loss of USD 5.3 million year ago

Aug 18 2016

BRIEF-MDxHealth announces positive medical policy for ConfirmMDx

* Announces positive medical policy for ConfirmMDx issued by one of the top five health insurers in the US

Aug 10 2016

BRIEF-MDxHealth and Cerba Healthcare collaborate on SelectMDx commercialization

* MDxhealth and Cerba Healthcare announce collaboration agreement for SelectMDx commercialization

Jul 25 2016

BRIEF-Mdxhealth secures new reimbursement coverage for SelectMdx

* Secures new reimbursement coverage for SelectMdx Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 28 2016

BRIEF-MDxHealth contracts with Priority Health for coverage of ConfirmMDx

* Contracts with Priority Health, a Michigan-based health plan with nearly 720,000 members, for coverage of ConfirmMDx for Prostate Cancer testing for its Commercial and Medicare Advantage members Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 23 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Wright Reports
$75.00
Provider : Reuters Investment Profile
$20.00
Provider : Sadif Analytics Prime
$25.00
Provider : Taglich Brothers Inc.
$161.00
Provider : Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.